Inhibitory anti-NBCn1 antibodies block net acid extrusion in human breast cancer tissue, particularly from patients with disseminated disease, and pH-dependently limit triple-negative breast cancer growth. This evidence concerns the gene SLC4A7 and triple-negative breast carcinoma.